Search clinical trials for: Beta adrenergic blockers

Total 17869 results

Seoul National University Hospital

Terminated

Rhythm Control Versus Rate Control for New Onset Atrial Fibrillation

Atrial Fibrillation New Onset | Atrial Fibrillation Paroxysmal

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers.

Overactive Bladder | Benign Prostatic Hyperplasia (BPH)

Korea, Republic of
University Hospital, Basel, Switzerland

Completed

Beta 2 Adrenergic Stimulation vs Cold Exposure to Activate Human Brown Adipose Tissue (ASCENT)

Thermogenesis

Switzerland
State University of New York at Buffalo
GlaxoSmithKline

Completed

Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril

Hypertension

United States
Martin Huelsmann

Recruiting

NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients

Heart Diseases | Diabetes Mellitus, Type 2

New Zealand, Austria, Netherlands, Spain, United Kingdom
Columbia University

Not yet recruiting

Postpartum Hypertension Study

Postpartum Preeclampsia | Hypertensive Emergency | Postpartum Pregnancy-Induced Hypertension | Pregnancy-Induced Hypertension in Postpartum

United States
Dow University of Health Sciences

Unknown

Comparison of Tab.Labetalol and Tab.Nifedipine for Management of Postpartum Hypertension

Postnatal Hypertension
Actavis Inc.

Completed

A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Carvedilol 25 mg in 36 Fasted, Healthy, Adult Subjects

Healthy

United States
University of Vigo
Hospital Clinico Universitario de Santiago; Xunta de Galicia; Ministerio de Educacion...

Completed

Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy (MAPEC)

Hypertension

Spain
Cardiff University

Completed

Comparison of Medical Therapies in Marfan Syndrome.

Marfan Syndrome

United Kingdom
Astellas Pharma Global Development, Inc.

Terminated

A Study to Evaluate Mirabegron in Pediatric Participants From 5 to Less Than 18 Years of Age With Overactive Bladder (OAB) (Dolphin)

Pharmacokinetics of Mirabegron | Overactive Bladder (OAB)

Korea, Republic of, Russian Federation, Turkey
Forest Laboratories

Completed

A Study on the Long-term Efficacy of Nebivolol After Withdrawal of Therapy

Hypertension

United States
Daniel Burdick, MD
Astellas Pharma US, Inc.

Completed

A Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease (MAESTRO) (Maestro)

Parkinsons Disease

United States
Ain Shams University

Unknown

Role of Intraoperative Beta Blocker for Morbid Obese Patients Undergoing Laparoscopic Bariatric Surgery

Postoperative Pain | Intraoperative Awareness

Egypt
HealthPartners Institute

Completed

Mirabegron in Parkinson Disease and Impaired Cognition (MICT-PD)

Overactive Bladder | Parkinson Disease | Impaired Cognition

United States
Astellas Pharma Inc

Completed

Pharmacokinetics of Oral Mirabegron With Different Release Rates Versus Intravenous (IV) Mirabegron

Healthy | Pharmacokinetics of Mirabegron

United States
Icahn School of Medicine at Mount Sinai
Forest Laboratories

Completed

Effect of Nebivolol on the Blood Flow in Hearts of Adults With High Blood Pressure and Abnormal Filling of Heart

Hypertension | Left Ventricular Diastolic Dysfunction

United States
Xijing Hospital

Completed

Supramaximal Titrated Inhibition of RAAS in Dilated Cardiomyopathy

Dilated Cardiomyopathy

China
Forest Laboratories

Completed

Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension

Stage 2 Hypertension | Stage 1 Hypertension

United States
Organon and Co

Completed

Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)

Hypertension
Novalead Pharma Private Limited

Completed

Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers

Diabetic Foot Ulcer

Malaysia, United States, India
SOM Innovation Biotech SA

Active, not recruiting

Efficacy and Safety on SOM3355 in Huntington's Disease Chorea

Huntington Chorea

Spain, Germany, Italy, United Kingdom, France, Poland, Switzerland
University Hospitals Cleveland Medical Center

Withdrawn

Comparison of Electroacupuncture to Mirabegron for Treatment of Overactive Bladder

Overactive Bladder

United States
Astellas Pharma Europe B.V.

Completed

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)

Overactive Bladder | Neurogenic Detrusor Overactivity

Denmark, Poland
Astellas Pharma Inc

Completed

A Study to Find Out How Much Mirabegron Gets Into the Body After Dosing With a Tablet Formulation

Healthy Subjects | Bioavailability | Pharmacokinetics of Mirabegron

Netherlands
Forest Laboratories

Completed

Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)

Hypertension

United States
Tanta University

Not yet recruiting

Clinical Study Evaluating the Gastroprotective Effect of Carvedilol in Patients With Ischemic Heart Disease on Aspirin Therapy

IHD | Gastro-Intestinal Disorder | Aspirin Induced Esophageal Ulcer
SWOG Cancer Research Network
National Cancer Institute (NCI)

Recruiting

S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer

Cardiotoxicity | Recurrent Breast Carcinoma | HER2/Neu Positive | Metastatic Malignant Neoplasm in the Brain | Stage IV Breast Cancer AJCC v6 and v7

United States, Korea, Republic of, Puerto Rico, Saudi Arabia
ShuGuang Hospital
Shanghai Zhongshan Hospital; Ruijin Hospital; Shanghai Public Health Clinical... and other collaborators

Unknown

Treatment of Moderate and Severe Cirrhotic Portal Hypertension Due to HBV With Fuzheng Huayu and Entecavir

Portal Hypertension

China
University of Arkansas
National Institute on Drug Abuse (NIDA); Baylor College of Medicine

Completed

Carvedilol for Psychostimulant Dependence

Cocaine Dependence | Cocaine Withdrawal

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Non-fasting Conditions

Healthy

Canada
Seoul National University Bundang Hospital

Unknown

Nicardipine Versus Labetalol During Intubation

Endotracheal Intubation | Patients Who Are Intubated for General Anesthesia

Korea, Republic of
David Haines, MD
Medtronic BRC

Terminated

Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial (Shock n Block)

Ventricular Fibrillation | Tachycardia, Ventricular | Cardiac Arrest | Sudden Cardiac Death

United States
Cairo University

Recruiting

Once Versus Twice Bisoprolol Dosage Regimen in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Surgery

Coronary Artery Disease | Postoperative Atrial Fibrillation | Coronary Artery Bypass Grafting

Egypt
Hospital de Base

Unknown

Effects of Intraoperative Esmolol on Post-mastectomy Pain Syndrome

Post-mastectomy Pain Syndrome

Brazil
Amsterdam UMC, location VUmc
ZonMw: The Netherlands Organisation for Health Research and Development

Unknown

Beta-blockers in i-PAH

Idiopathic Pulmonary Arterial Hypertension

Netherlands
Astellas Pharma Inc

Completed

A Clinical Study to Determine the Effect of YM178 on the Pharmacokinetics of Warfarin in Healthy Subjects

Overactive Bladder | Pharmacokinetics

France
Martin M. Miner, MD
Forest Laboratories

Unknown

Nebivolol Effects on Endothelial Function and Erectile Function (NEB-ED)

Erectile Dysfunction

United States
National Medical Research Center for Cardiology...

Recruiting

Study of Microvascular Dysfunction, CFR and Cardioprotective Effect of Early Administration of Esmolol in MI (ESMO-VASCMI)

Myocardial Infarction | Coronary Stenosis | Coronary Microvascular Dysfunction

Russian Federation
Astellas Pharma Global Development, Inc.

Recruiting

A Study of Mirabegron in Young Children With Neurogenic Detrusor Overactivity

Neurogenic Detrusor Overactivity

Philippines, Turkey, Belgium, Denmark
Tianjin Medical University General Hospital

Recruiting

Efficacy and Safety of Mirabegron in Intracerebral Hemorrhage

Intracerebral Haemorrhage

China
Mylan Bertek Pharmaceuticals

Completed

A Study Evaluating the Effects of Nebivolol on Blood Pressure in Hypertensive Patients

Hypertension

United States
Daiichi Sankyo, Inc.

Completed

A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin

Hypertension | Metabolic Syndrome | Insulin Resistance

United States
Forest Laboratories

Completed

Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation.

Atrial Fibrillation

Germany, France, Belgium, Hungary, Italy, Netherlands, Poland, Russian Federation, Spain
Cedars-Sinai Medical Center

Terminated

Esmolol Infusion During Laminectomy: Effect on Quality of Recovery

Laminectomy

United States
Hopital Foch

Terminated

Influence of Esmolol on a Closed-Loop Anesthesia System

Anesthesia

France
Astellas Pharma Europe B.V.

Completed

A Study to Assess the Systemic Pharmacokinetics, Metabolism and Excretion Routes of YM178 in Man, After Administration of Radio-labeled YM178

Metabolic Processes

Netherlands
Yonsei University

Unknown

Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic Patients (RECOVER)

Liver Cirrhosis | Portal Hypertension

Korea, Republic of
Nova Scotia Health Authority
Nova Scotia Health Research Foundation

Completed

Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF (SMAC AF)

Atrial Fibrillation

Canada

Search clinical trials for: Beta adrenergic blockers

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations